These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25483631)

  • 21. Willingness to pay for oral cholera vaccines in urban Bangladesh.
    Sarker AR; Islam Z; Sultana M; Sheikh N; Mahumud RA; Islam MT; Meer RV; Morton A; Khan AI; Clemens JD; Qadri F; Khan JAM
    PLoS One; 2020; 15(4):e0232600. PubMed ID: 32353086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine.
    Panda S; Chatterjee P; Deb A; Kanungo S; Dutta S
    Vaccine; 2020 Feb; 38 Suppl 1():A148-A156. PubMed ID: 31405636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.
    Hsiao A; Desai SN; Mogasale V; Excler JL; Digilio L
    Bull World Health Organ; 2017 Apr; 95(4):303-312. PubMed ID: 28479625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; Clemens JD; Raina MacIntyre C; Qadri F
    Vaccine; 2017 Sep; 35(37):5043-5049. PubMed ID: 28765003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.
    Heyerdahl LW; Ngwira B; Demolis R; Nyirenda G; Mwesawina M; Rafael F; Cavailler P; Bernard Le Gargasson J; Mengel MA; Gessner BD; Guillermet E
    Vaccine; 2018 Oct; 36(44):6491-6496. PubMed ID: 29126808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.
    Choudhary M; Solomon R; Awale J; Dey R
    BMC Infect Dis; 2018 May; 18(1):222. PubMed ID: 29769034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways to a policy for cholera control in India.
    Sekhar A; Kang G
    Vaccine; 2020 Feb; 38 Suppl 1():A157-A159. PubMed ID: 31266672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.
    Mahalanabis D; Lopez AL; Sur D; Deen J; Manna B; Kanungo S; von Seidlein L; Carbis R; Han SH; Shin SH; Attridge S; Rao R; Holmgren J; Clemens J; Bhattacharya SK
    PLoS One; 2008 Jun; 3(6):e2323. PubMed ID: 18523643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014.
    Scobie HM; Phares CR; Wannemuehler KA; Nyangoma E; Taylor EM; Fulton A; Wongjindanon N; Aung NR; Travers P; Date K
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005210. PubMed ID: 27992609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
    Poncin M; Zulu G; Voute C; Ferreras E; Muleya CM; Malama K; Pezzoli L; Mufunda J; Robert H; Uzzeni F; Luquero FJ; Chizema E; Ciglenecki I
    Bull World Health Organ; 2018 Feb; 96(2):86-93. PubMed ID: 29403111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
    Schwerdtle P; Onekon CK; Recoche K
    Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global oral cholera vaccine use, 2013-2018.
    Pezzoli L;
    Vaccine; 2020 Feb; 38 Suppl 1(Suppl 1):A132-A140. PubMed ID: 31519444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decades of cholera in Odisha, India (1993-2015): lessons learned and the ways forward.
    Khuntia HK; Ramamurthy T; Bal M; Pati S; Ranjit M
    Epidemiol Infect; 2021 Jun; 149():e148. PubMed ID: 34096499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.
    Schaetti C; Ali SM; Chaignat CL; Khatib AM; Hutubessy R; Weiss MG
    PLoS One; 2012; 7(7):e41527. PubMed ID: 22844489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-licensure deployment of oral cholera vaccines: a systematic review.
    Martin S; Lopez AL; Bellos A; Deen J; Ali M; Alberti K; Anh DD; Costa A; Grais RF; Legros D; Luquero FJ; Ghai MB; Perea W; Sack DA
    Bull World Health Organ; 2014 Dec; 92(12):881-93. PubMed ID: 25552772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    Raghava Mohan V; Raj S; Dhingra MS; Aloysia D'Cor N; Singh AP; Saluja T; Kim DR; Midde VJ; Kim Y; Vemula S; Narla SK; Sah B; Ali M
    PLoS One; 2019; 14(6):e0218033. PubMed ID: 31211792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.